Universal Stabilization Technologies
PrivateLast Round
Grant
Jun 23, 2021
Total Funding Raised
$2.5M
Company Overview
Universal Stabilization Technologies operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in June 2021.
Universal Stabilization Technologies is a biopharmaceutical R&D company that provides stabilization and delivery enabling technologies for vaccines and biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Universal Stabilization Technologies Comparables
Compare Universal Stabilization Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elarex Inc. | 87% | |
| Inaedis Inc. | 85% | |
| BioWraptor | 83% |
For institutional investors. Book with your work email.
Universal Stabilization Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 23, 2021 | ||||
| Grant | Jul 27, 2018 | ||||
| Grant | Feb 10, 2015 |
For institutional investors. Book with your work email.
Universal Stabilization Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2021
$596K grant received from National Institute of Allergy and Infectious Diseases.
- Jul 27, 2018
$600K grant from National Institute of Allergy and Infectious Diseases.
For institutional investors. Book with your work email.
Universal Stabilization Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Universal Stabilization Technologies's valuation, stock price, and market status.
Is Universal Stabilization Technologies a public or private company?
Universal Stabilization Technologies is a private company.
What is the current stock price of Universal Stabilization Technologies?
Universal Stabilization Technologies is a private company, so its shares have no public market price. Caplight tracks Universal Stabilization Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Universal Stabilization Technologies worth (valuation)?
Valuation information for Universal Stabilization Technologies is not publicly available.
Can I buy Universal Stabilization Technologies stock?
Universal Stabilization Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Universal Stabilization Technologies's last funding round?
Universal Stabilization Technologies's most recent funding round was Grant on June 23, 2021.
Who are the main investors in Universal Stabilization Technologies?
Key investors in Universal Stabilization Technologies include National Institute of Allergy and Infectious Diseases.
Will Universal Stabilization Technologies IPO soon?
No public IPO plans have been announced for Universal Stabilization Technologies.
How can I track Universal Stabilization Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Universal Stabilization Technologies's shares on secondary markets.